OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Organ Transplantation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Survival in adult lung transplantation: where are we in 2020?	130
Uterus transplantation worldwide: clinical activities and outcomes	45
Artificial intelligence and organ transplantation: challenges and expectations	26
Nonmedical barriers to early steps in kidney transplantation among underrepresented groups in the United States	24
Continuous distribution as an organ allocation framework	23
Current status of porcine islet xenotransplantation	23
The artificial pancreas	22
Gender and racial disparities in the transplant surgery workforce	20
Ethical considerations in xenotransplantation: a review	16
Development of a UK liver transplantation selection and allocation scheme	16
Elucidating measures of systemic racism to mitigate racial disparities in kidney transplantation	15
Update on islet cell transplantation	15
Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis	15
Update on Nocardia infections in solid-organ transplantation	14
Machine-learning algorithms for predicting results in liver transplantation: the problem of donor–recipient matching	13
United States liver allocation	13
The time is now: antimicrobial stewardship in solid organ transplantation	13
The current status and outlook of trachea transplantation	13
Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption	12
Kidney transplantation following uncontrolled donation after circulatory death	12
Mitochondria and ischemia reperfusion injury	12
Viability testing during liver preservation	12
Artificial intelligence in transplantation (machine-learning classifiers and transplant oncology)	12
Biomarkers of rejection in liver transplantation	12
Current status of pediatric intestinal transplantation in the United States	12

New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment	11
Current status of intestinal transplantation in East Asia	11
Update on immunosuppressive strategies in intestinal transplantation	11
Long-term outcomes of intestinal transplantation	11
New insights into the indications for intestinal transplantation	11
Tolerance studies in liver transplantation: are we fooling ourselves?	11
Donor-specific antibodies in lung transplantation	11
Gender disparities in transplantation	11
Geographic disparities in transplantation	10
Disparities in heart and lung transplantation	10
Grant monitoring after intestinal transplantation	10
An opposing view to United States liver allocation problems with broader sharing	10
Antibody-mediated rejection: prevention, monitoring and treatment dilemmas	10
Current state of adult intestinal transplantation in Europe	10
Current status of normothermic ex-vivo perfusion of cardiac allografts	10
Current status of pediatric mechanical circulatory support	9
Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing	9
The past the present and the future of face transplantation	9
Novel approaches in uterus transplantation	9
Cardiac evaluation of the kidney or liver transplant candidate	9
The rise and fall of the model for end-stage liver disease score and the need for an optimized machine learning approach for liver allocation	9
The evolving role of ECMO in liver transplantation	9
Pancreas preservation: clinical practice and future developments	9
An update on frailty in lung transplantation	8
Current status of adult liver transplantation: utilization of living donor versus deceased donor graft	8
Role of the purinergic signaling network in lung ischemia-reperfusion injury	8
Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process	8
Intestinal transplantation	8
Comparing bowel lengthening procedures: which, when, and why?	8
MicroRNAs: small molecules, big effects	8
Cardiac donation after circulatory death	8
Developments in immunosuppression	8
Access to liver transplantation for minority populations in the United States	8
Cell-free DNA in lung transplantation: research tool or clinical workhorse?	8
The use of organs from hepatitis C virus-viremic donors into uninfected recipients	8
Donor-specific antibody and sensitized patients in intestinal transplantation	8
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation	8
A detailed analysis of the current status of intestinal transplantation in Latin America	8
Adult intestinal transplantation in the United States	7
Alloimmunity in pancreas transplantation	7
Increased-risk donors and solid organ transplantation: current practices and opportunities for improvement	7
The role of non-HLA antibodies in solid organ transplantation: a complex deliberation	7
Recent advances in precision medicine for individualized immunosuppression	7
Immune benefit of combined heart and liver transplantation	7
Liver perfusion strategies: what is best and do ischemia times still matter?	7
Total artificial heart as a bridge to transplantation	7
Ethics of allocation of donor organs	7
Current status of left lobe adult to adult living donor liver transplantation	7
Redefining marginality: donor lung criteria	7
The emerging psychosocial profile of the adult congenital heart disease patient	7

Lung transplant programs in developing countries: challenges, solutions, and outcomes	7
Antibody-medicated rejection after heart transplantation: diagnosis and clinical implications	6
Mycobacterium tuberculosis in solid organ transplant donors and recipients	6
Quality of life after intestinal transplantation	6
Precision transplant pathology	6
Heart transplantation candidacy	6
Procedural mechanical support for lung transplantation	6
Expanding access to pancreas transplantation for type 2 diabetes mellitus	6
Pediatric kidney transplantation in the United States	6
Considerations and experience driving expansion of combined heart–liver transplantation	6
The impact of the gut microbiome on liver transplantation	6
Machine learning methods in organ transplantation	6
Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes	6
New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients	6
Normothermic regional perfusion for donation after circulatory death donors	5
Intestinal transplantation: an overview of the recent experimental studies	5
New insights into the microbiome in kidney transplantation	5
Obesity and kidney transplantation	5
Pancreas transplantation	5
Uterus transplantation – donor and recipient work-up	5
The current state of artificial intelligence in cardiac transplantation	5
Normothermic machine perfusion of kidneys: current strategies and future perspectives	5
A detailed analysis of the current status of intestinal transplantation in the middle east	5
Marginal parental donors for pediatric living donor liver transplantation	5
Technical advancements in epigenomics and applications in transplantation	5
Uterus transplantation: ethical considerations	5
Organ allocation in the age of the algorithm: avoiding futile transplantation – utility in allocation	5
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	5
The solid organ transplant recipient with SARS-CoV-2 infection	5
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics	5
Skin xenotransplantation: technological advances and future directions	5
Disparities in living donation	5
Ethical and societal challenges in penis transplantation	5
Delayed graft function: current status and future directions	5
Age disparities in transplantation	5
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	5
Development and outcomes of the French liver allocation system	5